Glenmark gets OAI classification from USFDA for Monroe site

"The OAI classification implies inter‐alia that the USFDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved," the company said in a statement to stock exchanges in the late evening Tuesday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Yo8T2zv
via IFTTT